Breakout Sessions 

Wed Sessions↓

    Tuesday • March 30

3:00-3:30pm EST 
The Future Of Telemedicine

Roy Schoenberg, President & CEO,
Amwell

The pandemic quickly turned telemedicine skeptics into believers. In this session. consider which trends are here to stay, and how your company should respond.

• How telemedicine has changed the physician practice landscape, and how much of that change is permanent
• What this means for physician practice revenues and budgets
• How to connect your product sales strategies to a telemed-enabled environment

3:45-4:15pm EST
Recovery and Growth Opportunities As Non-Acute Providers Rebound

Non-acute providers took a huge financial hit during the early months of the pandemic, and now they’re looking for opportunities to rebound. Discuss ideas on:

• Which factors will most impact non-acute providers’ recovery
• What the non-acute landscape will look like, post-pandemic
• How medical products companies can help providers make a comeback

4:30-5:00pm EST 
What’s Ahead For In-Person Patient-Physician Interactions

Tom Schwieterman, M.D.
Vice President of Clinical Affairs and Chief Medical Officer,
Midmark Corporation

Face-to-face interactions between patients and providers aren’t going away, but they already look different. In this session, get a look at the future of in-person care.

• PPE, supplies, and equipment requirements
• Balancing comfort, cost, and patient experience

3:00-3:30pm EST
Reinventing Distribution Value, Post-Pandemic

The COVID-19 pandemic has challenged distribution like nothing before. News reports asked “why is the supply chain broken?” rather than recognizing the critical value distributors played in expanding product availability to customers despite demand spikes and supply shutdowns. Get insights on:

• What pandemic experiences and news coverage could mean for distribution’s role in the future
• How the flood of unknown suppliers highlighted the value of trusted supply chain partners
• Why it’s more critical than ever to educate providers, policymakers, and the public about the value of distribution

3:45-4:15pm EST 
The Financial Impact of COVID On Hospitals and Health Systems

The pandemic took a huge financial toll on most hospitals and IDNs, and the road to financial recovery will be a long one. Get expert opinions on what’s ahead for the coming months:

• What providers are doing to stabilize their finances
• Why elective procedures are so critical
• How trading partners can help

4:30-5:00pm EST
How Financial Transparency Requirements Will Change Hospitals

Hospitals are grappling with a new 2021 rule that requires them to disclose prices in a simple format that helps patients avoid surprise out-of-pocket costs. Understand:

• Why it’s so difficult for hospitals to fully understand their own costs and pricing
• What investments they’ll need to make to comply
• How the new rule will likely impact provider and patient decision-making

    Wednesday • March 31

2:00-2:30pm EST 
Convalescing From COVID: The Road Ahead For Post-Acute Providers

Mark Parkinson, President & CEO,
American Health Care Association (AHCA)

COVID-19 has been especially brutal for nursing homes. People in long-term care facilities have accounted for less than 10% of all coronavirus cases but 45% of COVID-19 deaths – 70,000 patients and staff as of mid-August. Find out what it will take for nursing facilities to recover, and what the industry may look like when the pandemic is over.

• How nursing homes can weather the negative financial impacts of COVID-19
• What types of providers are most at risk
• How their business partners can help

2:45-3:15pm EST
How The COVID Experience Will Change Post-Acute Providers’ Supply Chain Strategies
Owen Hammond, President & CEO, Cascadia Health

Most nursing homes and other long-term care facilities had fairly simple supply chain needs and structures prior to the pandemic  – many didn’t even have so much as a purchasing agent. COVID-19 hit hard, and these facilities needed PPE and other products they’d never used before and couldn’t easily acquire. In this session, consider:

• How the supply chain will reorganize to better serve post-acute providers
• What manufacturers and distributors can do to best support this market
• Where the greatest challenges and opportunities lie

3:30-4:00pm EST
The Future For Home Health And Hospice

Three months into the pandemic, 90% of home health agencies reported a decline in admissions and revenue. Some clients paused services because family members were able to provide care while working from home; others refused to allow caregivers into the home for risk of exposure. Many hospice organizations were similar affected.

• Understand how well and how quickly home health and hospice providers are recovering
• Find out how their menu of services is evolving to better support current customer concerns and needs
• Discuss the role of supply chain partners in home care’s post-pandemic success

2:00-2:30pm EST 
Elevating Diagnostics in the Post-COVID Healthcare Environment

Robert Michel, Editor-in-Chief,
DARK Daily and the Dark Report

A year ago, lab testing was the behind-the-scene factor driving the vast majority of medical decisions. As the pandemic progressed, diagnostics moved front-and-center, with policymakers, media, and consumers discussing the merits of different methodologies and the importance of expanded testing. 

• How can the diagnostics industry leverage its greatly increased visibility?
• How might the COVID experience impact product approvals, reimbursement, and other key policy decisions in the future?

---

2:45-3:15pm EST
COVID Testing: What's Happening Now, And What's Ahead













Mike Abney, SVP Distribution Strategy,
Quidel Corporation


Jim Poggi, Director, Vendor Relations,
AvMedical

Since the pandemic began, the diagnostics industry has been overwhelmingly focused on development and distribution of Covid tests: faster PCR products, more accurate antigen tests, and more meaningful antibody assays. In this session, explore what’s next:

• Demand for COVID testing as vaccination expands
• The growing role of antibody tests
• Key questions from providers as they navigate changing diagnostics requirements

---

3:30-4:00pm EST 
Trends in Diagnostics Distribution



Emily Berlin, VP, Product Marketing,
Cardinal Health


Robert Kovar, Sr. Director,
Marketing & Business Development,
Thermo Fisher Scientific


Erik Ringberg, VP, Lab Category Mgmt.,
McKesson Medical-Surgical

Diagnostics manufacturers depend on a strong partnership with distributors to create demand, educate providers, and deliver products to lab customers nationwide. Take part in this candid discussion with lab distributors for insights on:

• Where testing will be delivered, and how to best reach those market segments
• What policy and payment rules are currently driving opportunities for diagnostics growth
• How to build sales and marketing support from your supply chain partners